thirdsector    thirdsectorjobs

GSK

GSK

GSK

GSK

Biography

What is the project?
GSK’s partnership with Save the Children supports work to save children’s lives in 41 different
countries.Two multi-million-pound flagship programmes, in the Democratic Republic of Congo
(DRC) and Kenya, tackle severe challenges in the supply of and demand for effective healthcare for
mothers and their babies.

How is the company involved?
Combining GSK's scientific expertise with Save the Children's experience of vulnerable communities
allows the partnership to employ research and development to help some of the hardest to reach
mothers and children. For example, the partnership has reformulated chlorhexidine, an ingredient in
a GSK mouthwash, to create a gel used to prevent neonatal sepsis, a major cause of newborn death.
Through GSK's skill-based volunteer scheme, PULSE, more than 100 GSK employees have worked
with Save the Children across 32 countries. GSK employees also support the partnership through
fundraising programme Orange United, with 444 Orange United Ambassadors from 51 countries.
Total employee fundraising since launch in 2013 is now over £3 million.

What has it achieved?
Between September 2016 and August 2017, 14,738 children in Kenya and 39 537 children in the
DRC were reached though the partnership’s lifesaving interventions, with more than 2.6 million
children reached to date. Over 97,600 children have been fully immunised, over 187,800 children
treated for malaria, pneumonia or diarrhoea and more than 16,000 health workers have been
trained.

The 20% Reinvestment Initiative, where GSK reinvests profits to improve healthcare infrastructure,
allows Save the Children to deliver programmes in 14 countries. In each country the partnership has
strengthened the core health infrastructure by building the capacity of frontline health workers. In Mali
in 2017, the project influenced national government to double its health worker budget, leading to the
recruitment of 900 skilled health workers.GSK’s partnership with Save the Children supports work to save children’s lives in 41 different
countries.Two multi-million-pound flagship programmes, in the Democratic Republic of Congo
(DRC) and Kenya, tackle severe challenges in the supply of and demand for effective healthcare for
mothers and their babies.

How is the company involved?
Combining GSK's scientific expertise with Save the Children's experience of vulnerable communities
allows the partnership to employ research and development to help some of the hardest to reach
mothers and children. For example, the partnership has reformulated chlorhexidine, an ingredient in
a GSK mouthwash, to create a gel used to prevent neonatal sepsis, a major cause of newborn death.
Through GSK's skill-based volunteer scheme, PULSE, more than 100 GSK employees have worked
with Save the Children across 32 countries. GSK employees also support the partnership through
fundraising programme Orange United, with 444 Orange United Ambassadors from 51 countries.
Total employee fundraising since launch in 2013 is now over £3 million.

What has it achieved?
Between September 2016 and August 2017, 14,738 children in Kenya and 39 537 children in the
DRC were reached though the partnership’s lifesaving interventions, with more than 2.6 million
children reached to date. Over 97,600 children have been fully immunised, over 187,800 children
treated for malaria, pneumonia or diarrhoea and more than 16,000 health workers have been
trained.

The 20% Reinvestment Initiative, where GSK reinvests profits to improve healthcare infrastructure,
allows Save the Children to deliver programmes in 14 countries. In each country the partnership has
strengthened the core health infrastructure by building the capacity of frontline health workers. In Mali
in 2017, the project influenced national government to double its health worker budget, leading to the
recruitment of 900 skilled health workers.